Publications

EuroSpA publication A4.1

Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey Click here to access full article

EuroSpA publication D8.2

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European  rheumatology registries Click here to access full article

EuroSpA publication BX.2

Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis Click here to access full article

EuroSpA publication BX.1

Effect of Online Training on the Reliability of Assessing Sacroiliac Joint Radiographs in Axial Spondyloarthritis: A Randomized, Controlled Study Click here to access full article

EuroSpA publication 4.3

Comparing DAPSA, DAPSA28, and DAS28-CRP in PatientsWith Psoriatic Arthritis Initiating a First Tumor NecrosisFactor Inhibitor Across Nine European Countries Click here to access full article

EuroSpA publication A1.2

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study Click here to access full article

EuroSpA publication D6.1

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors Click here to access full article

EuroSpA publication D8.1

Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? Click here to access full article

EuroSpA publication D3.1

Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response Click here to access full article

EuroSpA publication 1.3

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment Click here to access full article

EuroSpA publication 2.1

Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis Click here to access full article This publication is featured in Editor's Picks Spotlight by the Journal of Rheumatology, see the interview with Lykke Ørnbjerg here:

EuroSpA publication D1.1

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network Click here to access full article

EuroSpA publication A1.1

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice Click here to access full article

EuroSpA publication D1.2

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network Click here to access full article

EuroSpA publication E.1

Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration Click here to access full article

EuroSpA publication 1.4

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching Click here to access full article Plain language video presentation: Plain language summary EuroSpA publication 1.4, interview with Louise Linde Plain language summary text: [...]

EuroSpA publication A2.1

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe Click here to access full article Plain language summary (in danish) Featured in Magasinet om Rygsøjlegigt, May 2024

EuroSpA publication 4.1

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries Click here to access full article Plain language video presentation: Plain language summary EuroSpA publication 4.1, interview with Louise Linde Plain language summary [...]

EuroSpA publication 2.2

One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment Click here to access full article Plain language video presentation: Plain language summary EuroSpA publication 2.2, interview with Lykke Ørnbjerg Plain language summary text: [...]

Go to Top